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INTRODUCTION
In recent years, histochemistry at light and
electron microscopy has increasingly been
applied to investigate basic mechanisms
of skeletal muscle diseases; in particular,
the study in situ of skeletal muscle cell
nuclei proved to be crucial for elucidating
some pathogenetic mechanisms of skele-
tal muscle wasting in myotonic dystrophy
(DM) and sarcopenia. DM is an autosomal
dominant disorder whose multisystemic
features originate form nucleotide expan-
sions: (CTG)n in the dystrophy myotonic
protein kinase (DMPK) gene on chromo-
some 19q13 in DM type 1 (DM1), or
(CCTG)n in intron 1 of the CNBP gene
(previously known as zinc finger 9 gene,
ZNF9) on chromosome 3q21 in DM type
2 (DM2). Sarcopenia is an age-related con-
dition characterized by the decline of mus-
cle mass, strength, and function, whose
causes are still poorly known and proba-
bly manifold (e.g., altered levels of anabolic
hormones and inflammatory mediators,
impairment of proteolytic and autophagic
pathways, mitochondrial or neuromus-
cular dysfunction, and loss of satellite
cells). Interestingly, skeletal muscles in both
DM and sarcopenia show myofiber atro-
phy, fiber size variability, and centrally
located nuclei, as well as a reduced satel-
lite cells’ effectiveness. Based on ex vivo
and in vitro studies, we have demonstrated
that both myofibers and satellite cells of
DM and sarcopenic muscles exhibit a mas-
sive nuclear rearrangement of the struc-
tural and molecular factors responsible
for pre-mRNA transcription and matura-
tion; the impairment in the pre-mRNA
post-transcriptional pathways would thus
account for the aging-reminiscent muscle
phenotype of DM patients suggesting that
the skeletal muscle wasting observed in DM
and sarcopenia may result from similar
cellular mechanisms.
HISTOLOGICAL PHENOTYPE OF
SKELETAL MUSCLE IN SARCOPENIA
AND MYOTONIC DYSTROPHY
Myotonic dystrophy is an autosomal dom-
inant disorder causing multiorgan and
multisystemic pathological features among
which muscular dystrophy, characterized
at the histopathological level by fiber size
variability with concomitantly occurring
dystrophy and hypertrophy, and presence
of myofibers with centralized or grouped
nuclei (nuclear clumps) (Bertoni-Freddari
et al., 2004). Two types of DM exist; the
more severe Steinert’s disease (DM1) show-
ing dystrophy of slow/type I fibers, and
the milder DM2 or proximal myotonic
myopathy (PROMM), where fast/type II
fibers are affected (Bertoni-Freddari et al.,
2004; Biggiogera et al., 2008). It is widely
accepted that the pathogenesis of DMs
essentially depends on the expansion of tri-
or tetra-nucleotide sequences resulting in
the intranuclear accumulation of expanded
transcribed RNAs. DM1 is caused by
an expansion of a (CTG)n nucleotide
sequences in the 3′ untranslated region
(3′-UTR) of the DMPK gene, located on
chromosome 19 (ch19q13) (Brook et al.,
1992; Cardani et al., 2006; Bogolyubov
et al., 2009), whereas in DM2 a (CCTG)n
repeat expansion occurs in intron 1 of
the cellular nucleic acid-binding protein
(CNBP) gene (previously know as zinc fin-
ger 9 gene, ZNF9) (Cmarko et al., 1999) on
chromosome 3 (ch3q21.3) (Cruz-Jentoft
et al., 2010).
Sarcopenia is the age-related condition
characterized by the progressive loss of
mass, strength, and function of skeletal
muscles; it occurs, in humans, from the
age of 50 affecting even healthy, physically
active subjects and contributing to frailty,
disability, and premature death (Fu et al.,
1992; Fakan, 2004; Edstrom et al., 2007).
A reduction in the size of muscle fibers
occurs with selective atrophy of the fast,
type II fibers resulting in the shift in muscle
fiber composition, fiber size heterogeneity,
and centrally located nuclei (Giagnacovo
et al., 2011, 2012). The mechanisms causing
sarcopenia are still incompletely elucidated
and likely manifold, including altered lev-
els of anabolic hormones and inflamma-
tory mediators, impairment of the prote-
olytic and autophagic pathways, mitochon-
drial or neuromuscular dysfunction, loss of
satellite cells’ effectiveness, and myonuclei
depletion.
Interestingly, the skeletal muscles of DM
patients share apparent similarities with
the aging muscle; under both conditions,
fiber size variability with grouped atrophy
and centrally located or clumped nuclei
are observed, while the muscle regenera-
tion capabilities are decreased, likely due to
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a reduced responsiveness of satellite cells
to activating stimuli or a failure in their
myogenic effectiveness (Huichalaf et al.,
2010).
STRUCTURAL AND FUNCTIONAL
ALTERATIONS OF SKELETAL MUSCLE
CELL NUCLEI IN MYOTONIC
DYSTROPHY AND SARCOPENIA
In eukaryotic cells, primary transcripts
(pre-mRNAs) undergo extensive modifica-
tions before becoming mature mRNAs to
be exported to the cytoplasm. This pro-
cessing occurs in the spliceosome, i.e., the
molecular complex composed of five small
nuclear ribonucleoproteins (snRNPs) (U1,
U2, U4/U6, and U5 snRNPs) and many
non-snRNP splicing factors, as well as
by a large number of regulating mol-
ecules (Kanadia et al., 2003). The pre-
mRNA maturation events mostly occur
co-transcriptionally, with the simultane-
ous presence of different molecules at the
transcription sites. At transmission elec-
tron microscopy, the fine fibrillar struc-
tures at the edge of heterochromatin called
perichromatin fibrils (PF) are the in situ
form of nascent transcripts [reviewed in
Koopman and van Loon (2009)] as well as
of their splicing (Lexell, 1995) and 3′ end
processing (Liquori et al., 2001). Part of the
mature mRNA may migrate through the
interchromatin space toward the nuclear
pores as PF, while another part accumu-
lates in the perichromatin granules, i.e.,
roundish RNP structures in the perichro-
matin region acting as vectors and storage
sites for already spliced pre-mRNAs (Koop-
man and van Loon, 2009). Storage, assem-
bly, and phosphorylation of transcription
and splicing factors take place in the inter-
chromatin granules (IG) that occur in the
interchromatin space and are not directly
involved in pre-mRNA processing (Llorian
and Smith, 2011).
The intranuclear distribution of the
RNP-containing structures demonstrates
that RNA processing is chronologically
and spatially ordered; whenever tran-
scription and/or splicing are altered, the
organization, molecular composition, and
intranuclear location of RNP-containing
structures are also affected (Mahadevan
et al., 1992; Malatesta, 2012).
Defects in the RNA pathways have been
documented both in DM and sarcopenia.
In DM cells, the expanded CUG-
and CCUG-containing transcripts accu-
mulate in the nucleus forming typical foci
(Cmarko et al., 1999), which sequester
the splicing factors CUG-binding pro-
tein 1 (CUGBP1) and muscleblind-like 1
(MBLN1) (Malatesta et al., 2005, 2010a,b).
These factors are essential for the alterna-
tive splicing of many transcripts especially
coding for contractile proteins, and their
sequestration leads to abnormal expression
of protein isoforms (Malatesta et al., 2007,
2011a).
Our in vitro studies on DM2 fibrob-
lasts (Malatesta et al., 2011b) revealed
that MBNL1-containing foci are dynamic
domains undergoing periodic accumula-
tion (during interphase) and degradation
(at mitosis) in cycling cells, whereas in non-
proliferating cells, the foci cannot undergo
degradation and progressively increase in
number and size in senescing cells. This
explains the different impact of DM on
different tissues and organs; in cells from
self-renewing tissues (such as skin fibrob-
lasts or layering epithelial cells), the cyclic
degradation of the foci prevents a massive
intranuclear sequestration of MBNL1 thus
reducing the pathological effects, while tis-
sues where non-renewing cells are mainly
present (e.g., the skeletal muscle, heart, and
the central nervous system) are much more
affected. The size of foci and, consequently,
the MBNL1 sequestration rate also increase
with aging, as demonstrated by longitudi-
nal studies on skeletal muscles from DM2
patients (Malatesta et al., 2011b).
It is worth noting that DM foci do
not sequester alternative splicing regula-
tors only but also contain hnRNPs and
snRNPs, i.e., essential spliceosomal com-
ponents involved in early pre-mRNA pro-
cessing (Malatesta et al., 2011c).
In addition to its sequestration into the
nuclear foci, MBNL1 also shows an altered
intranuclear distribution in myonuclei of
DM skeletal muscle, occurring not only
on PF, where it plays post-transcriptional
functions, but also on IG, where it is usu-
ally absent in healthy subjects (Malatesta
et al., 2013). The high resolution and speci-
ficity of ultrastructural techniques allowed
to demonstrate that MBNL1 is not depleted
in DM myonuclei but actually accumulates
on RNP components while the amount of
heterochromatin increases, thus suggesting
a concomitant reduction of transcribing
DNA.
In skeletal muscle biopsies, we also
demonstrated that many molecular factors
responsible for pre-mRNA transcription
and maturation (i.e., snRNPs, hnRNP, and
CstF) undergo accumulation and altered
intranuclear distribution in both DM1 and
DM2 (Malatesta and Meola, 2010); as a
consequence, the function of the whole
splicing machinery would be affected and
the molecular trafficking slowed down,
reducing protein synthesis in DM myocytes
(Mankodi et al., 2003; Malatesta et al.,
2009).
Alterations of nuclear features such
as impairment of pre-mRNA maturation
pathways and accumulation of heterochro-
matin have been also found in DM satellite-
cell-derived myoblasts in vitro (Martin
et al., 1979); these myoblasts also show
cytoplasmic vacuolization and reduction
of the proteosynthetic apparatus, and dif-
ferentiate into myotubes exhibiting struc-
tural defects similar to senescent healthy
myotubes (Meola and Cardani, 2014). This
suggests that DM satellite cells have a
reduced regeneration capability, and may
generate defective myotubes thus con-
tributing to the muscular dystrophy.
In sarcopenia, foci have never been
observed in myonuclei; however, factors
acting in the post-transcriptional process-
ing of pre-mRNA accumulate in PF and
sometimes in IG, where they do not reg-
ularly localize (Meola and Moxley, 2004;
Perdoni et al., 2009). In particular, the alter-
native splicing factor, MBNL1 undergoes
similar relocation in the myonuclei of DM
and aged skeletal muscle (Malatesta et al.,
2013).
This intranuclear clustering/
rearrangement of RNP structures con-
taining splicing and cleavage factors was
observed not only in skeletal muscle but
also in other tissues (e.g., liver and brain)
from aged subjects (Ranum et al., 1998),
and frequently associates to an increased
heterochromatin content (Ryall et al., 2008;
Salisbury et al., 2009; Malatesta, 2012).
This indicates that in aging cells, the entire
production chain of mRNAs, from the syn-
thesis to the cytoplasmic export, becomes
less efficient reducing cell responsiveness
to metabolic stimuli. Such a reduced react-
ing capability, which is typical of elderly,
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would be especially critical for skeletal
muscles, where a deregulation of the pro-
tein turnover may lead to a prevalence
of proteolysis versus proteosynthesis with
catastrophic consequences on the myofiber
structure (Schul et al., 1996).
Abnormal intranuclear distribution of
splicing factors has been described in satel-
lite cells of aged muscles, suggesting that
RNA pathways undergo alterations also
in these quiescent cells, possibly ham-
pering their response to muscle damage
(Taneja et al., 1995; Perdoni et al., 2009).
Accordingly, ultrastructural and immuno-
cytochemical studies on in vitro cultured
satellite-cell-derived myoblasts from old
skeletal muscles revealed altered nuclear
features (low amounts of pre-mRNA tran-
scription and processing factors, increased
amounts of heterochromatin, and compact
nucleoli) and cytoplasmic modifications
(vacuolization, reduced proteosynthetic
apparatus, and disorganized cytoskeleton);
in addition, these myoblasts have dramat-
ically reduced myogenic capability giving
rise to structurally and functionally defec-
tive myotubes (Malatesta et al., submitted).
COMMON NUCLEAR FEATURES
ACCOUNTING FOR THE SARCOPENIC
AND DYSTROPHIC MUSCLE
PHENOTYPE
The experimental evidence here summa-
rized highlights that sarcopenia and DM
share not only similar abnormalities of
the skeletal muscle histological features but
also similar nuclear alterations of the struc-
tural and molecular constituents involved
in transcription and pre-mRNA matu-
ration (Verdijk et al., 2007; Thompson,
2009). As a consequence, important dys-
functions in the nuclear RNA pathways
occur, which are likely responsible, through
a cascade effect, for the multiple pheno-
typic alterations at the tissue and cellu-
lar level observed in the skeletal mus-
cles from DM patients and sarcopenic
subjects.
The deregulation of alternative splic-
ing due to MBNL1 loss-of-function and,
at least for DM1, to the increased CUGBP1
activity has for a long time been regarded
as the exclusive cause of the multiple
pathological features of DMs (Malatesta
et al., 2009); however, in recent years,
some authors have hypothesized that the
molecular mechanisms involved in DM
pathogenesis might be much more com-
plex than previously thought on the basis
of disrupted alternative splicing. Accord-
ingly, MBNL1 depletion alone is not able
to mimic the DM-like muscle wasting in
knockout mice (Vihola et al., 2003).
Using multiple immunolabeling
techniques at transmission electron
microscopy, it was possible to detect, at
high resolution, and to quantify specific
protein factors in the very place where
they localize in myocytes and satellite cells
from sarcopenic and dystrophic subjects;
by this approach, we demonstrated that
MBNL1 is not markedly depleted in DM
skeletal muscle nuclei but rather re-locates
(in association with other splicing factors)
to transcriptionally inactive domains as
much as it occurs in the skeletal mus-
cle nuclei from sarcopenic individuals.
Moreover, combined fluorescence and
immunoelectron microscopy conclusively
demonstrated that, in DM skeletal muscle,
nuclear foci sequester not only MBNL1
but also two major classes of splicing fac-
tors – snRNPs and hnRNPs – which are
essential for the early processing phases of
pre-mRNAs (Malatesta et al., 2011c).
It has repeatedly been demonstrated
that the proper location and composition
of the RNP-containing nuclear domains
is an essential pre-requisite for transcrip-
tion and pre-mRNA processing to cor-
rectly take place (Mahadevan et al., 1992).
Under normal conditions, a balance exists
between the amount of nascent hnR-
NAs and the quantity of protein needed
for their processing. If transcription is
reduced (as in sarcopenia), this condi-
tion cannot be reached, and the RNP
proteins that have a relatively long half-
life (Wahle and Rüegsegger, 1999) become
exceedingly predominant over the newly
formed hnRNA, and may form unusual
ectopic association with other protein fac-
tors (Mahadevan et al., 1992); at the oppo-
site, when an especially high quantity of
RNA accumulates in the nucleus (as it
occurs with the expanded RNA repeats in
DMs), different RNA-binding proteins are
sequestered giving rise to heterogeneous
RNP aggregates: in either case and irre-
spective of the causing event, the splicing
machinery is altered thus hampering the
whole RNA maturation process.
Ex vivo and in vitro studies demon-
strated that both myofibers and satellite
cells of DM and sarcopenic muscles exhibit
a massive nuclear reorganization of the
RNP-containing domains where the mol-
ecular factors responsible for pre-mRNA
transcription and maturation do localize;
we hypothesize that the impairment in the
RNA post-transcriptional pathways may
account for the aging-reminiscent muscle
phenotype of DM patients suggesting that
the skeletal muscle wasting observed in DM
and sarcopenia may result from similar
cellular mechanisms.
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